
Nu Skin Enterprises (NUS) | Stock Overview & Key Data
Nu Skin Enterprises Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $140.50 on January 13, 2014
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Nu Skin Enterprises NUS | 580.61M Small-cap | -0.52% | 32.94% | 56.32% | 49.74% | 73.48% | 13.80% | -73.08% | -76.14% |
Procter & Gamble PG | 371.03B Mega-cap | 3.25% | 2.39% | -4.05% | -6.76% | -4.37% | -6.17% | 11.55% | 14.38% |
Colgate-Palmolive CL | 68.76B Large-cap | 1.93% | -0.42% | -5.88% | -3.57% | -4.72% | -17.21% | 8.93% | 8.71% |
Spectrum Brands SPB | 1.37B Small-cap | -6.44% | -2.31% | -9.40% | -31.24% | -34.79% | -40.65% | -16.95% | -8.85% |
Edgewell Personal EPC | 1.09B Small-cap | 0.43% | -8.18% | -14.68% | -24.03% | -30.23% | -41.77% | -43.41% | -20.11% |
Yatsen Holding YSG | 874.24M Small-cap | 1.05% | -0.52% | 98.76% | 147.42% | 150.00% | 186.57% | 45.45% | -90.41% |
Ownership & Short Interest
Nu Skin Enterprises Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Nu Skin Enterprises would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NUS's 52-week high and low?
- In the last 52 weeks, Nu Skin Enterprises reached a high of $12.23 (on August 19, 2025) and a low of $5.32 (on April 21, 2025).
- What is the market cap and P/E ratio for NUS?
- Curious about Nu Skin Enterprises's size and valuation? Its market capitalization stands at 580.61M. When it comes to valuation, the P/E ratio (trailing twelve months) is 5.78, and the forward P/E (looking ahead) is 11.28.
- Does NUS pay dividends? If so, what's the yield?
- Yes, Nu Skin Enterprises is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.32%, and the company has paid an average of $0.75 per share annually over the past 3 years.
- Who are Nu Skin Enterprises's main competitors or similar companies to consider before investing?
When looking at Nu Skin Enterprises, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Procter & Gamble
PG371.03B Consumer Defensive Household & Personal Products -6.17% 11.55% Colgate-Palmolive
CL68.76B Consumer Defensive Household & Personal Products -17.21% 8.93% Spectrum Brands
SPB1.37B Consumer Defensive Household & Personal Products -40.65% -16.95% Edgewell Personal
EPC1.09B Consumer Defensive Household & Personal Products -41.77% -43.41% Yatsen Holding
YSG874.24M Consumer Defensive Household & Personal Products 186.57% 45.45% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nu Skin Enterprises Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Nu Skin Enterprises's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.68%, the Debt to Equity ratio from the most recent quarter is 43.06, and its Gross Profit Margin stands at 68.82%.
- What is the recent revenue and earnings growth for NUS?
- Looking at Nu Skin Enterprises's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.10%, and quarterly earnings saw a YoY growth of -12.06%.
- How much of NUS stock is held by insiders and institutions?
- Wondering who owns Nu Skin Enterprises stock? Company insiders (like executives and directors) hold about 2.23% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 74.84%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.